ASPG and acute lymphoblastic leukemia: Since its introduction in the 1970s, in fact, the anti-metabolism drug l-Asparaginase has become a key component of the combined chemotherapy scheme used in pediatric Acute Lymphoblastic Leukemia (ALL) treatment, playing a decisive role in increasing complete remissions achieved up to 90% in patients [8].